undamentalytics Newsletter
Sign in

Rapid Micro Biosystems, Inc. balance sheet

At the end of fiscal 2025, Rapid Micro Biosystems, Inc. had total assets of $74.9m, total liabilities of $41.6m and shareholders' equity of $33.2m. It held $20.0m in cash against $18.9m of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents301782724172015
Receivables5556836
Inventory9162120201819
Total current assets62218139120816146
Total assets70241191143987558
Accounts payable4452345
Deferred revenue (current)4356756
Total current liabilities16181919181818
Long-term debt2500—01919
Total debt2500001919
Total liabilities45202625234241
Shareholders' equity−127221164118753318
Non-controlling interests and other (assets − liabilities − equity)152——————

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: MXCT vs RPIDOABI vs RPIDBNGO vs RPIDRPID vs TKNO

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Rapid Micro Biosystems, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Rapid Micro Biosystems, Inc.